CEACAM5 and neoplasm: Wang et al22 combined the use of the serum tumor markers carcinoembryonic antigen, CA15‐3, CA125, CA19‐9, and tissue polypeptide‐specific antigen to improve the efficiency of metastatic breast cancer diagnosis.